Beam Therapeutics (BEAM) Profit After Tax (2019 - 2025)
Historic Profit After Tax for Beam Therapeutics (BEAM) over the last 7 years, with Q3 2025 value amounting to -$112.7 million.
- Beam Therapeutics' Profit After Tax fell 1661.36% to -$112.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$414.6 million, marking a year-over-year decrease of 18876.67%. This contributed to the annual value of -$376.7 million for FY2024, which is 18427.57% down from last year.
- Latest data reveals that Beam Therapeutics reported Profit After Tax of -$112.7 million as of Q3 2025, which was down 1661.36% from -$102.3 million recorded in Q2 2025.
- Beam Therapeutics' 5-year Profit After Tax high stood at $142.8 million for Q4 2023, and its period low was -$201.6 million during Q1 2021.
- Its 5-year average for Profit After Tax is -$78.6 million, with a median of -$91.1 million in 2024.
- As far as peak fluctuations go, Beam Therapeutics' Profit After Tax plummeted by 56176.37% in 2021, and later surged by 47236.17% in 2023.
- Over the past 5 years, Beam Therapeutics' Profit After Tax (Quarter) stood at -$64.7 million in 2021, then surged by 40.73% to -$38.3 million in 2022, then surged by 472.36% to $142.8 million in 2023, then plummeted by 163.27% to -$90.4 million in 2024, then dropped by 24.76% to -$112.7 million in 2025.
- Its Profit After Tax stands at -$112.7 million for Q3 2025, versus -$102.3 million for Q2 2025 and -$109.3 million for Q1 2025.